Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%

Healthcare

Page 92
  1. Dec 02, 2025 · 17:01 · VIVI

    TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market

    TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market

    01
  2. Dec 02, 2025 · 17:01 · DTR

    DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test

    DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test

    02
  3. Dec 02, 2025 · 09:54 · PHRM

    PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise

    PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise

    03
  4. Dec 02, 2025 · 09:11 · HEM

    Hemostemix to Attend DFCon San Antonio and Closed its Private Placement

    Hemostemix to Attend DFCon San Antonio and Closed its Private Placement

    04
  5. Dec 02, 2025 · 08:00 · AIDR

    Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth

    Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth

    05
  6. Dec 02, 2025 · 07:30 · BCT

    BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS(TM) 2025

    BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS(TM) 2025

    06
  7. Dec 02, 2025 · 07:30 · VITA

    Vitalist and MicroEJ Announce New Reebok Smartwatch Powered by VitalOS(TM)

    Vitalist and MicroEJ Announce New Reebok Smartwatch Powered by VitalOS(TM)

    07
  8. Dec 02, 2025 · 07:01 · FRX

    Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK(TM) in Japan to Reduce Cisplatin-Induced Hearing Loss

    Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK(TM) in Japan to Reduce Cisplatin-Induced Hearing Loss

    08
  9. Dec 02, 2025 · 07:00 · VST

    Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

    Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

    09
  10. Dec 02, 2025 · 07:00 · NURS

    Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

    Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

    10
  11. Dec 01, 2025 · 22:29 · VST

    Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update

    Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update

    11
  12. Dec 01, 2025 · 18:00 · 4875

    Message from the CEO to MediciNova Shareholders

    Message from the CEO to MediciNova Shareholders

    12
  13. Dec 01, 2025 · 17:45 · MVMD

    Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization

    Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization

    13
  14. Dec 01, 2025 · 17:05 · CSCI

    COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen(TM) in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

    COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen(TM) in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

    14
← Newer Older →